Pfizer plans to manufacture up to 100 million doses of omicron-specific vaccine by spring
Companies, agencies, institutions, etc
Pfizer
JPMorgan Chase
April.”Rapid
Moderna
BioNTech
Codex
The Centers for Disease Control and Prevention
Johns Hopkins University
Congress
Pfizer and
Omicron
White House
The White House
the Department of Health and Human Services
the Food and Drug Administration
the Immunization Action Coalition
Merck
| Booster
| Education
People
Albert Bourla
Steven Danehy
Stéphane Bancel
Robbie Silverman
Anthony S. Fauci
John Grabenstein
Tracker
|
| Delta
Groups
German
Americans
African
Democrats
mRNA
British
Physical locations
Africa
Places
No matching tags
Locations
San Diego
Israel
Cameroon
The United States
China
U.S.
Events
No matching tags
Summary
The company is trying to create a single-dose, annual shot that will address multiple respiratory viruses, he said, “a franchise that will evolve every year.”But as drug manufacturers scramble to keep up with waning immunity and mutations, the demand for boosters and, potentially, variant-targeting vaccines and hybrids is causing alarm among global health authorities and advocates.Citing inequitable distribution patterns over the past year, they say most of the additional shots will be reserved by wealthy nations and further delay the time Africa and developing countries elsewhere get their populations substantially vaccinated.Israel has authorized fourth shots for people who are elderly or have compromised immune systems.
As said here by Christopher Rowland